NEMLUVIO® is a new and novel treatment for prurigo nodularis (PN) that offers fast itch relief in a convenient dosing.(1,2) Finally, a treatment for PN with less frequent doses than the other biologic.(1,3) 1. NEMLUVIO (nemolizumab-ilto) injection 30 mg Prescribing Information. Dallas, TX: Galderma Laboratories, L.P.; August 2024. 2. Data on File: Continuous Treatment Group from PN Olympia 2 and LTE (REF-18414) 3. DUPIXENT. Prescribing Information. Sanofi Genzyme; 2023. Important Safety Informat

Time to block out sleepless nights. NEMLUVIO® delivers fast and lasting relief for less sleepless nights.(1) The secret is that NEMLUVIO® is a first-of-its kind treatment that blocks IL-31 signaling, a key driver of itch and inflammation.(2) Ask a dermatology specialist about NEMLUVIO: https://bit.ly/4mi6MyD​ Important Safety Information​ Indication: NEMLUVIO® (nemolizumab-ilto) is a prescription medicine used to treat adults with prurigo nodularis. Contraindication: Known hypersensitivity to NE